Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanchez-Soto

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Molecular Pharmacology|August 3, 2018
Identification of Positive Allosteric Modulators of the D<sub>1</sub> Dopamine Receptor That Act at Diverse Binding SitesKathryn D Luderman, Jennie L Conroy, R Benjamin Free, et al.
Oncogene|August 10, 2022
BTLA<sup>+</sup>CD200<sup>+</sup> B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancerBrian Diskin, Salma Adam, Gustavo Sanchez Soto, et al.
Oncogene|January 27, 2023
Correction to: BTLA<sup>+</sup>CD200<sup>+</sup> B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancerBrian Diskin, Salma Adam, Gustavo Sanchez Soto, et al.
Nature Communications|October 13, 2019
High-potency ligands for DREADD imaging and activation in rodents and monkeysJordi Bonaventura, Mark A G Eldridge, Feng Hu, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Molecular Pharmacology|August 3, 2018
Identification of Positive Allosteric Modulators of the D<sub>1</sub> Dopamine Receptor That Act at Diverse Binding SitesKathryn D Luderman, Jennie L Conroy, R Benjamin Free, et al.
Oncogene|August 10, 2022
BTLA<sup>+</sup>CD200<sup>+</sup> B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancerBrian Diskin, Salma Adam, Gustavo Sanchez Soto, et al.
Oncogene|January 27, 2023
Correction to: BTLA<sup>+</sup>CD200<sup>+</sup> B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancerBrian Diskin, Salma Adam, Gustavo Sanchez Soto, et al.
Nature Communications|October 13, 2019
High-potency ligands for DREADD imaging and activation in rodents and monkeysJordi Bonaventura, Mark A G Eldridge, Feng Hu, et al.
Pageof 3